Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Express Scripts
Cipla
US Department of Justice
Cantor Fitzgerald
Harvard Business School
Covington
Chubb
Federal Trade Commission

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,157,456

« Back to Dashboard

Summary for Patent: 7,157,456
Title:Substituted oxazolidinones and their use in the field of blood coagulation
Abstract: The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I) ##STR00001## processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described.
Inventor(s): Straub; Alexander (Wuppertal, DE), Lampe; Thomas (Wuppertal, DE), Pohlmann; Jens (Wuppertal, DE), Rohrig; Susanne (Essen, DE), Perzborn; Elisabeth (Wuppertal, DE), Schlemmer; Karl-Heinz (Wuppertal, DE), Pernerstorfer; Joseph (Wuppertal, DE)
Assignee: Bayer HealthCare AG (Leverkusen, DE)
Application Number:10/181,051
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

Drugs Protected by US Patent 7,157,456

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Janssen Pharms XARELTO rivaroxaban TABLET;ORAL 022406-001 Jul 1, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y TREATMENT OF PULMONARY EMBOLISM (PE) ➤ Try a Free Trial
Janssen Pharms XARELTO rivaroxaban TABLET;ORAL 022406-001 Jul 1, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y TREATMENT OF DEEP VEIN THROMBOSIS (DVT) ➤ Try a Free Trial
Janssen Pharms XARELTO rivaroxaban TABLET;ORAL 022406-002 Nov 4, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y TREATMENT OF DEEP VEIN THROMBOSIS (DVT) ➤ Try a Free Trial
Janssen Pharms XARELTO rivaroxaban TABLET;ORAL 022406-002 Nov 4, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y TREATMENT OF PULMONARY EMBOLISM (PE) ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,157,456

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 62 924Dec 24, 1999
PCT Information
PCT FiledDecember 11, 2000PCT Application Number:PCT/EP00/12492
PCT Publication Date:July 05, 2001PCT Publication Number: WO01/47919

Non-Orange Book US Patents Family Members for Patent 7,157,456

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,592,339 Substituted oxazolidinones and their use in the field of blood coagulation ➤ Try a Free Trial
8,129,378 Substituted oxazolidinones and their use in the field of blood coagulation ➤ Try a Free Trial
8,530,505 Substituted oxazolidinones and their use in the field of blood coagulation ➤ Try a Free Trial
7,576,111 Substituted oxazolidinones and their use in the field of blood coagulation ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,157,456

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 032436 ➤ Try a Free Trial
Austria 289605 ➤ Try a Free Trial
Australia 2004218729 ➤ Try a Free Trial
Australia 2841401 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
UBS
Dow
Farmers Insurance
Teva
Express Scripts
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.